PRESCRIBING CHANGES IN RESPONSE TO US FOOD AND DRUG ADMINISTRATION ACCELERATED VS. REGULAR APPROVAL OF ONCOLOGY THERAPIES
Driving Knowledge to Action: Building a Better Future With Artificial Intelligence–Enabled Multidisciplinary Oncology
Evaluating generalizability of oncology trial results to real-world patients using machine learning-based trial emulations
Coronary Microvascular Dysfunction in Men with Prostate Cancer Receiving Androgen-Deprivation Therapy
Clinician- and Patient-Directed Communication Strategies for Patients With Cancer at High Mortality Risk: A Cluster Randomized Trial
The COVID-19 Pandemic Led To A Large Decline In Physician Gross Revenue Across All Specialties In 2020
Hospice Administrators' and Providers' Perspectives on Providing Upstream Palliative Care: Facilitators, Barriers, and Policy Prescriptions
Real-world Uptake of Enfortumab Vedotin plus Pembrolizumab after US Food and Drug Administration Approval Among Patients with Advanced Urothelial Cancer
Association of Participation in Medicare's Oncology Care Model With Spending, Utilization, and Quality Outcomes Among Commercially Insured and Medicare Advantage Members
"Start low, go slow," a strategy to tailor treatment dosing in older or vulnerable adults with advanced solid cancer: A systematic review and meta-analysis
Using the Translational Science Benefits Model to assess the impact of the Penn Implementation Science Center in Cancer Control
Real-World and Clinical Trial Validation of a Deep Learning Radiomic Biomarker for PD-(L)1 Immune Checkpoint Inhibitor Response in Advanced Non-Small Cell Lung Cancer
Patient perspectives on treatment and prevention of recurrent urinary tract infections: a focus group study
Association of Remote Patient-Reported Outcomes and Step Counts With Hospitalization or Death Among Patients With Advanced Cancer Undergoing Chemotherapy: Secondary Analysis of the PROStep Randomized Trial
